Articles > T1D Exchange

T1D Exchange Quality Improvement Coalition Panel Tackles Issues of Type 1 Diabetes Care

They agreed that technology, if properly implemented, can augment the clinic visit, among other topics. The panel took place at the 2019 T1D Exchange annual meeting in Cambridge, MA.

The Evolution of Real-World Evidence in Drug and Device Development

At the T1D Exchange annual meeting, two FDA officers discuss the changing regulatory landscape for drugs and devices.

At the T1D Exchange annual meeting, Wendy Wolf, PhD, discusses the successful launch of T1D Exchange Registry.

Researchers have discovered that an increase of a particular type of microRNA in the bloodstream appears to herald the onset of type 1 diabetes.

Check out a live stream of T1D Exchange’s Annual Meeting 2019 in Cambridge, MA: Live Stream The event has featured speakers from the FDA, faculty from our Quality Improvement Collaborative, and more. Join us online for insights, questions, and discussion panels!

FDA experts and Clinicians to Speak at the T1D Exchange Annual Meeting on September 23rd

-T1D Exchange staff On September 23rd, T1D Exchange will hold its annual meeting at the Royal Sonesta in Cambridge, Massachusetts. The theme of this year’s meeting is data–and the  organization’s commitment to use it alongside collaboration to improve outcomes for individuals with type 1 diabetes. In the keynote address, “The Evolution of Real-World Evidence in […]

Word Choice Matters in Diabetes Care

In a recent webinar, a T1D Exchange diabetes researcher and an Ohio University associate professor presented the clinical impact of diabetes stigma, and how health care professionals can use person-first language to foster a collaborative conversation with people with diabetes.

A Lifetime with Type 1 Diabetes, a Career of Service to the Type 1 Diabetes Community

A profile of Charlie Iacono, managing director of commercial partnerships and advancement for T1D Exchange.

Diabetes Supplies-1778-650

A recent multinational collaboration found that the percentage of children over the age of 6 years living with type 1 diabetes (T1D) who use insulin pumps is higher in the US than in England, Wales, Germany, and Austria, and in all of these countries, HbA1c levels were lower among pump users. In this collaboration, investigators […]